New obesity drug, Meridia

March 1998

    Knoll is promoting their new obesity drug, Meridia.

    Meridia (sibutramine) inhibits the reuptake of norepinephrine and serotonin. It helps reduce appetite and increase metabolism.

    Meridia leads to about a 5% to 10% weight loss. This doesn't sound like much, but it's sometimes enough to decrease the risk of hypertension, diabetes, etc.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote